Healthcare

Insulin Pump Market Size is Forecasted to Reach US$ 13.37 billion by 2030

The global insulin pump market size is forecasted to reach from US$ 4.29 billion in 2021 to US$ 13.37 Billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 13.5% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 and 2020, the forecast period considered is from 2021 to 2030. The insulin pump market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1413

The global insulin pump market is driven by various factors such as rising prevalence of diabetes among the population, rising consumer expenditure on healthcare, rising demand for innovative drug delivery devices, and constant investments in the development of innovative and convenient drug delivery solutions. According to the International Diabetes Federation, the global diabetic population is expected to reach at 552 million by 2030.

The diabetic patients are required to regularly monitor their blood glucose levels and take regular insulin shots to control diabetes. The alarming rise in the diabetic population owing to the unhealthy food habits and rising consumption of various drinks that contains sugar. Moreover, the increasing penetration of the retail pharmacies and rising awareness regarding the availability of the insulin pumps is exponentially fostering the demand for the insulin pumps across the globe.

Scope of the Insulin Pump Market

Report Coverage Details
Market Size in 2020 US$ 3.8 Billion
Growth Rate From 2021 to 2030 CAGR of 13.5%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030

Market Dynamics

Driver

The rising prevalence of the diabetes across the globe

As per the IDF Diabetes Atlas Ninth Edition 2019, around 463 million people of age 20 to 79 years were suffering from diabetes and this number is projected to reach 700 million by 2045. In 2019, around 4.2 million deaths were recorded due to diabetes. Moreover, the children are now diagnosed with type 1 diabetes. Around 1.1 million adolescents and children were living with diabetes in 2019. Furthermore, around 374 million people have higher risks to develop type 2 diabetes. Therefore, the surging prevalence of type 1 and type 2 diabetes are expected to drive the growth of the global insulin pump market during the forecast period.

Restraint

High costs of the insulin pumps and inadequate reimbursement facilities

Most of the patients depend on the reimbursements for getting the treatment for various diseases. The high cost of the insulin pumps along to the inadequate reimbursement facilities are restricting the adoption of the insulin pumps and this may hamper the growth of the global insulin pump market.

Opportunities

Integration of latest technologies with the drug delivery devices

The latest technologies like artificial intelligence (AI) is expected to encourage the adoption of the automated insulin pumps in the forthcoming years. Moreover, the latest insulin pumps are facilitating the smartphones to be connected with the insulin pumps and are offering the control of doses and acting as a blood glucose monitoring devices.

Challenges

Lack of access to proper healthcare infrastructure

The inadequate healthcare infrastructure in the developing and underdeveloped regions is resulting in the lack of awareness regarding the diabetes and insulin pumps. According to the IDF, around 232 million diabetic people remained undiagnosed in 2019. This is a major challenge to the insulin pump market that may restrict its growth.

Competitive Landscape Analysis:

Some of the leading companies operating in the insulin pump market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Major companies operating in this report are

  • Medtronic Plc
  • Insulet Corporation
  • Medzer
  • Microport Scientific
  • Eoflow
  • Debiotech S.A.
  • Lenomed Medical
  • Microtech Medical
  • Cequr SA
  • F. Hoffmann La Roche AG
  • Ypsomed AG
  • Zealand Pharma
  • Terumo Corporation
  • Vicentra B.V.

Report Highlights

  • Based on the pump type, the patch pump is estimated to be the most opportunistic segment during the forecast period. This is due to the rising adoption of the patch pumps as it offers convenience and easy attachment to the skin surface and efficient drug delivery. It is gaining popularity among the patients owing to its compact size.
  • Based on the accessories, the reservoirs segment is expected to be the fastest-growing segment during the forecast period owing to the rising adoption of the tethered insulin among the diabetic population. The capacity of the reservoirs is around 300 doses that can go for 3 days is offering improved conveniences.
  • Based on the end user, the homecare segment is expected to grow at the fastest CAGR. The increasing penetration of the online and the offline retail pharmacies across the globe is facilitating easy availability of the insulin pumps and the increased awareness regarding the insulin pumps is fueling the growth of the homecare segment.

Regional Snapshot

North America dominated the global insulin pump market in 2020. North American nations like the US and Canada has increased presence of highly aware population that significantly spends on the healthcare products. The increasing prevalence of diabetes among the population is a major factor that drives the demand for the insulin pumps in North America. According to the CDC, around 10.5% or about 34.2 million of the US population had diabetes in 2018. Furthermore, the high disposable income and increased penetration of the retail pharmacies, hospitals, and clinics in the region are supplementing the market growth.

Asia Pacific is expected to be the most opportunistic market during the forecast period. The rising prevalence of diabetes along with the surging awareness about the benefits of the insulin pumps is boosting the demand. Moreover, rising healthcare expenditure along with the surging penetration of online retail channels is fueling the growth of the insulin pump market in this region. The nations like India, China, South Korea, Australia, and Japan are the most prominent market in Asia Pacific, owing to the rising adoption of the innovative drug delivery technologies. Moreover, as per the IDF, around 79% of the adult diabetic population in the globe is living in the low and middle-income economies in 2019.

Market Segmentation

By Pump Type

  • Tethered Pump
  • Patch Pump

By Application

  • Battery
  • Insulin Set Insertion Devices
  • Insulin Reservoir

By Disease Indication

  • Type 1 Diabetes
  • Type 2 Diabetes

By End User

  • Hospitals
  • Clinics
  • Homecare
  • Laboratories

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Why should you invest in this report?

If you are aiming to enter the global insulin pump market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for insulin pump are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1413

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Insulin Pump Market 

5.1. COVID-19 Landscape: Insulin Pump Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Insulin Pump Market, By Pump

8.1. Insulin Pump Market, by Pump Type, 2021-2030

8.1.1. Tethered Pump

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Patch Pump

8.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Insulin Pump Market, By Application

9.1. Insulin Pump Market, by Application, 2021-2030

9.1.1. Battery

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Insulin Set Insertion Devices

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Insulin Reservoir

9.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Insulin Pump Market, By Disease Indication Type 

10.1. Insulin Pump Market, by Disease Indication Type, 2021-2030

10.1.1. Type 1 Diabetes

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Type 2 Diabetes

10.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Insulin Pump Market, By End User Type 

11.1. Insulin Pump Market, by End User Type, 2021-2030

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2019-2030)

11.1.2. Clinics

11.1.2.1. Market Revenue and Forecast (2019-2030)

11.1.3. Homecare

11.1.3.1. Market Revenue and Forecast (2019-2030)

11.1.4. Laboratories

11.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 12. Global Insulin Pump Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Pump (2019-2030)

12.1.2. Market Revenue and Forecast, by Application (2019-2030)

12.1.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.1.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.1.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.1.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Pump (2019-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.1.6.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.1.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Pump (2019-2030)

12.2.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.2.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.2.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Pump (2019-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.6.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.2.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Pump (2019-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.7.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.2.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Pump (2019-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.8.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.2.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Pump (2019-2030)

12.3.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.3.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.3.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Pump (2019-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.6.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.3.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Pump (2019-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.7.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.3.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Pump (2019-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.8.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.3.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Pump (2019-2030)

12.4.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.4.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.4.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Pump (2019-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.6.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.4.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Pump (2019-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.7.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.4.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Pump (2019-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.8.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.4.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.5.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.5.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Pump (2019-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.5.6.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.5.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

Chapter 13. Company Profiles

13.1. Medtronic Plc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Insulet Corporation

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Medzer

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Microport Scientific

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Eoflow

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Debiotech S.A.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Lenomed Medical

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Microtech Medical

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Cequr SA

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. F. Hoffmann La Roche AG

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

13.11. Ypsomed AG

13.11.1. Company Overview

13.11.2. Product Offerings

13.11.3. Financial Performance

13.11.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1413

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Read Also:

  1. Ventilator Market Size to Reach Valuation of US$ 6.4 Billion By 2030
  2. E-textiles Market Size Predicted to Reach US$ 13.96 Billion by 2030
  3. Medical Implants Market Size is Forecasted to Reach US$ 145.6 billion by 2030
  4. Alternative Fuel Vehicle 2022 to 2030 – Industry Scope and Growth Strategies by Key Players, Vehicle Type, and Fuel Types
  5. Medical Electronics Market Size is Forecasted to Reach US$ 248.43 Billion by 2030
  6. Carbon Steel Market Estimated to Generate a Revenue of US$ 1,251.67 By 2030
  7. Medical Electronics Market Size is Forecasted to Reach US$ 248.43 Billion by 2030
Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button